baber/WOPTO huggingface dataset:
Patent JP-2000503922-A (JP)
Title: 液状複合材料の成形方法
IPC: B29K63/00
Filed: 1997-01-30
Abstract: (57)【要約】
本発明は、液状複合材料の成形方法に関するものである。液状の成形可能な樹脂、又は当該樹脂のための反応性成分を金型内に射出し、該金型内で硬化し、得られた成形品を金型から取り出す。液状樹脂又は反応性成分が金型内に射出される間、有機金属カップリング剤が存在していて、フィラーの分離を抑制する。
Patent JP-H11503222-A (JP)
Title: 空気を処理する方法と装置
IPC: A23L3/18
Filed: 1996-04-03
Abstract: (57)【要約】
多孔性のコンベヤーベルト(1)上を移送される製品(4)を空気処理する方法において、ベルトコンベヤーの下面に向かって空気流が吹き上げられる。こうしてコンベヤーベルトを通過し、製品同士の間を通り抜けた上方を指向する空気流は、、コンベヤーベルトの上方の或る距離において一時的に、コンベヤーベルトの面内に必然的に含まれる方向に偏向される。この方法を実施する装置は、その内部において、コンベヤーベルトの下面に向かって空気が吹き上げるハウジングを有する。１つの空気流偏向手段(5)が、コンベヤーベルトの上方でハウジング内に設けられ、この手段が、コンベヤーベルトを通過し、製品同士の間を通り抜けた上に向かって吹き上げる空気流を、コンベヤーベルトの面内に必然的に含まれる方向に一時的に変更させる。
Patent JP-H11503156-A (JP)
IPC: A61K31/436
Filed: 1996-04-01
Abstract: PCT No. PCT/US96/04163 Sec. 371 Date Oct. 2, 1997 Sec. 102(e) Date Oct. 2, 1997 PCT Filed Apr. 1, 1996 PCT Pub. No. WO96/31513 PCT Pub. Date Oct. 10, 1996This invention relates to intermediates and processes for the synthesis of camtothecin derivatives, such as irinotecan. Related procedures and compounds are disclosed, such as a method of making mappicine.
Patent JP-H11504104-A (JP)
Title: 流体流の冷却
IPC: F25B1/10
Filed: 1996-04-17
Abstract: (57)【要約】
主熱交換器（１）の高温側（１ｄ、１ｂ、１ｃ）を通る流体流を冷却する方法で、主熱交換器（１）から冷媒を取り出す段階と、冷媒を二段圧縮器（７）で圧縮することによって高圧の冷媒を得る段階と、冷媒を部分的に凝縮（１２）することによって第一二相流体を得ると共に、この第一二相流体を第一凝縮留分（１５）と第一気体留分（１６）に分離（１３）する段階と、第一凝縮留分（１５）を補助熱交換器（２）で冷却することによって低温の第一凝縮留分（１８）を得ると共に、第一気体留分（１６）を補助熱交換器（２）で冷却することによって、第二二相流体（２６）を得る段階とを備えて、液体を低温側（２ａ）で中間圧で蒸発させることによって冷却が行われるようにしており、さらに、第二二相流体を第二凝縮留分（３３）と第二気体留分（３２）に分離（２８）する段階と、第二凝縮留分の一部（４９）を補助熱交換器（２）の低温側（２ａ）で蒸発させる段階と、第二凝縮留分の残り（３３）を主熱交換器（１）で冷却して低温の第二凝縮留分を得ると共に、第二気体留分を主熱交換器（１）で冷却する段階とを備えて、主熱交換器（１）の低温側（１ａ）で低圧で液体を蒸発させることによって冷却が行われるようにした方法。
Patent JP-2001511176-A (JP)
IPC: A61P17/02
Filed: 1998-02-11
Abstract: An inhibitor of adhesion formation which can be used to prevent adhesions within the abdominal cavity, particularly following surgical intervention, trauma or inflammation in the area is disclosed. Specifically, the most preferred compound of the present invention. Halofuginone, can be used to prevent collagen deposition from occurring within the peritoneum after surgical intervention, thereby inhibiting adhesion formation. Halofuginone, and related compounds, are useful in the prevention and treatment of both inflammatory and surgically induced adhesions, and in the treatment of congenital adhesions.
Patent JP-2001516472-A (JP)
Title: 単一パネル光バルブのマルチカラーバンドスクロール
IPC: H04N9/31
Filed: 1998-12-07
Abstract: (57)【要約】
光バンド走査表示装置は、光バルブパネル及び光学系を含む。この光学系はマルチカラー光源及びプリズム面が形成され回転可能な光透過正多面プリズムを含む。光源は、赤、ミラー及び青の光バンドの像を形成する照明光を前記プリズムを経てそれぞれ異なる光路に沿って投射する。光学素子の組を、照明光が入射しパネル上に像を形成するように配置する。
Patent JP-H11505389-A (JP)
Title: ディスクリートコサイン変換を用いた色調回復のためのシステムおよび方法
IPC: G06T9/00
Filed: 1996-01-25
Abstract: (57)【要約】
画像のフルカラー解像度は、画像を表す画像信号から画像データポイントのアレイを再構築して、シフトされた疑似絵素アレイにすることによって実現される。アレイの特定のグリッドタイプによって、色調回復が垂直解像度のみを用いるか、水平解像度のみを用いるか、垂直解像度の後に水平解像度を用いるか、水平解像度の後に垂直解像度を用いるかが決まる。各色チャネルに関して、まず画像データポイントのＤＣＴを行い、その後ＤＣＴ係数の変形ＩＤＣＴを行うことによって、欠けている色成分の補間が行われる。
Patent JP-H11501521-A (JP)
Title: 複合毒素による昆虫駆除
IPC: A01N63/40
Filed: 1996-04-30
Abstract: (57)【要約】
鱗翅属などからの害虫の死滅速度を速める方法を提供する。本法は、少なくとも一つの組換え微生物から発現した少なくとも二つの異なる害虫毒素で害虫またはそれらの病巣を処理することを有する。同一の結合部位には競合せず、薬理学的性質の異なる毒素対が相乗的駆除を提供することを見出した。好ましい殺虫微生物はバクロウイルスである。
Patent JP-2001511255-A (JP)
Title: タイヤ均等性試験装置
IPC: G01M17/02
Filed: 1998-01-22
Abstract: (57)【要約】
タイヤ均等性試験装置は、ガントリー状フレーム構造上に取付けられた試験ステーション（１２）と、この試験ステーションに近接して設けられた取入コンベア（１０）とを備える。この取入コンベアはタイヤ（１０２）を受容し、タイヤ（１０２）の回転軸線（１５４）が試験ステーション（１２）の回転軸線（１５６）から所定距離に位置するようにタイヤ（１０２）を中心合わせし、コンベア（１００ａ）はタイヤを試験ステーション（１２）に搬送する。この試験ステーション（１２）は、フレームに取付けられた回転可能なチャックアセンブリ及び主軸アセンブリを備え、これらはタイヤ（２０）の踏面に係合してタイヤ（２０）を回転させるように回転される上側リム及び下側リムを備える。回転するタイヤ（２０）は、タイヤ（２０）の均等性を示す電気信号を生成する荷重輪（４２）により係合される。
Patent JP-2001515690-A (JP)
Title: Ｒｆアンプの拡散スペクトルパイロットを抽出する方法および装置
IPC: G10L19/10
Filed: 1999-01-13
Abstract: (57)【要約】
本発明は、ＳＳパイロットが逆拡散されＲＦ搬送波が拡散される前にＲＦ搬送波をクリッピングするような拡散スペクトル（ＳＳ）パイロット抽出システムに関する。ＲＦ搬送波のクリッピングによって、スペクトルにおけるノイズレベルは上昇する。しかし、このクリッピングによるインバンドノイズレベルにおける小さな上昇は、クリッピングの後に搬送波を拡散することによるインバンドＲＦノイズの減少と比べると大したことはなくなる。結果として、クリッピングの後に搬送波の拡散によってインバンドノイズが減少したことにより、逆拡散されたパイロットの検出レンジが拡張する。これによって、制御回路はパイロットとＩＭＤ成分の更なる相殺をすることができる。従って、フィードフォワードＲＦアンプに対するＳＳパイロット抽出システムは、最終出力カプラーにおける拡散スペクトルパイロットの抽出および検出を改善し、パイロットおよびＩＭＤの相殺を改善することができる。
Patent JP-2000510425-A (JP)
Title: コンテナおよびコンテナ台車を移送するターミナル
IPC: B65G63/02
Filed: 1998-03-05
Abstract: (57)【要約】
本発明は，コンテナ（７）を貨車（６）に搬入し，および／またはコンテナ（７）を積載した貨車（６）から搬出するためのターミナル（１）に関する。ターミナル（１）は，引き入れおよび/または引き出し部，およびこの引き入れおよび/または引き出し部，に沿って引き入れおよび/または引き出し部，に隣接して配列され，引き入れおよび/または引き出し部，よりも高いレベルにある搬入用および／または搬出用プラットフォーム（４，５），から構成される。引き入れおよび/または引き出し部，に向けて開口したスロット（５０）が，搬入用および／または搬出用プラットフォーム（４，５）に設けられ，これらスロット（５０）の間の距離は，搬入または搬出されるべきコンテナ（７）の長さよりも小さい。各スロット（５０）は，梁状サポート（５２）とともに与えられ，梁状サポート（５２）は，搬入用および搬出用プラットフォーム（４，５）に本質的に引き込んだ位置と，搬入または搬出されるべき貨車（６）の幅だけ本質的に突き出す位置との間にスロット（５）の縦方向に置き換えられる。本発明にしたがったターミナル（１）は，折畳み式の脚で自立できるコンテナをプラットフォーム上に降ろして置くためのターミナルとして使用できる。
Patent JP-2001515351-A (JP)
IPC: A61K47/48
Filed: 1998-03-03
Abstract: Replication-competent adenovirus vectors specific for cells which allow a probasin transcriptional response element (PB-TRE) to function, such as cells which express the androgen receptor (AR), and methods of use of such viruses are provided. These viruses comprise an adenoviral gene under control of a transcriptional regulatory portion of a PB-TRE, which is in turn dependent upon AR expression. The gene can be, for example, a gene required for viral replication or the adenovirus death protein gene (ADP). The viruses can also comprise at least one additional adenoviral gene under control of at least one additional prostate-specific transcriptional response element, such as that controlling prostate-specific antigen expression (PSA-TRE). Thus, virus replication can be restricted to target cells exhibiting prostate-specific gene expression, particularly prostate carcinoma cells. An adenovirus of the present invention can further comprise a heterologous gene such as a reporter under transcriptional control of a PB-TRE. The adenovirus vectors can be used to detect and monitor samples for the presence of prostate cells as well as to selectively kill malignant cells producing prostate-specific gene products.
Patent JP-2002500753-A (JP)
IPC: G01N21/78
Filed: 1998-03-06
Abstract: Systems, devices and methods are provided for viewing a pattern of fluorophors capable of fluorescing when exposed to visible light, e.g., fluorescently stained DNA, protein or other biological material. The system includes a light source emitting light in the visible spectrum, such as a fluorescent lamp used in domestic lighting, a first optical filter capable of transmitting light from the source at wavelengths capable of exciting the fluorophors and of absorbing light of other wavelengths, and a second optical filter capable of blocking substantially all the light from the source not blocked by the first filter, so that the only light reaching the viewer is light produced by fluorescence of the fluorophors.
Patent JP-2000512838-A (JP)
Title: 自己起動式ブラシレス電気モータ
IPC: H02K19/06
Filed: 1997-05-29
Abstract: (57)【要約】
自己起動式ブラシレス電気モータは、第１の極列に配置された極（1５Ｓ，１６Ａ）を備えた第１のモータ部分（ステータ）（１１）を有し、上記極は各巻線相に対して極グループ（１３）を含み、上記極グループ（１３）は磁気抵抗極味（１５Ｓ）および永久磁石極（1６Ａ）を含む極対を含み、各巻線相にはこのような極グループが１つだけ設けられる。自己起動式ブラシレス電気モータはさらに第２のモータ部分（ロータ）（１２）を有し、第２のモータ部分（１２）は第１のモータ部分（１１）に対して移動可能であり、かつ第１の極列に対向する第２の極列に配置された磁気抵抗極（1８Ａ）を備える。自己起動式ブラシレス電気モータはさらに第１のモータ部分（１１）上に磁化巻線（１７）を有する。極列のうちの少なくとも一方は、巻線が励磁されるとモータ部分（１１，１２）を好ましい相対的な方向に移動させる磁気的非対称性を示す。第１の極列の極対の極（１５Ｓ，１６Ａ）は隔てられるため、この対の極が第２の極列の極（1８Ａ）と磁気的に整列するときは常に、この対の他方の極が第２の極列の隣接する次の極と磁気的に整列しないようになる。強磁性の補助極手段（２０）は第１のモータ部分（１１）上に設けられ、上記対の永久磁石極（１６Ａ）が第２の極列の極（１８Ａ）と磁気的に整列するときに常に、補助極手段（２０）が、極列を隔てる空隙（１９）を介して第２の極列の他の極のうちの少なくとも１つに面するように位置付けられる。
Patent JP-2001518027-A (JP)
Title: 印刷インクと清掃液とを印刷ユニットに供給する方法と供給するためのポンプユニット
IPC: B41F31/08
Filed: 1998-03-24
Abstract: (57)【要約】
印刷インクを印刷ユニット（２）に供給するポンプユニット（１）が記載され-Cいる。印刷ユニット（２）をできるだけ有効に利用しかつ異なる印刷インクカラーを取替える時間を最短とするため上記のポンプユニット（１）には印刷インクタンク（27）と清掃液タンク（28）とが設けられる。清掃液及び印刷インクをポンプで吸引し又は戻すためのパイプ（33，34）が一方又は他方のタンク（27,28）上の位置から摺動される。インク付けの処理段階と清掃の処理段階とが中央制御ユニット（44）によって制御されそれにより操作員にとって必要な操作が新しい印刷インクカラーを印刷ユニット（２）に適用する時の印刷インクタンク（22）の取替えのみとなるようにする。
Patent JP-2002507116-A (JP)
IPC: C07H1/08
Filed: 1998-05-13
Abstract: The present invention provides a method of isolating nucleic acid from a sample of cells, said method comprising: (a) binding cells in said sample in a solid support to isolate cells from the sample; (b) lysing the isolated cells; and (c) binding nucleic acid released from said lysed cells to said same solid support and a kit for carrying out such a method. The method may advantageously be used to prepare nucleic acid for use in a nucleic acid-based target cell detection method.
Patent MD-20050064-A (MD)
Inventor: BOSTAN ION
IPC: B21D43/00
Filed: 2005-03-04
Abstract: Inventia se refera la industria constructoare de masini, in special, la durificarea suprafetei pieselor de prelucrat prin deformare plastica. Dispozitivul pentru realizarea procedeului de moletare a dintilor rotilor conice cu durificarea suprafetei lor include un batiu 1 instalat coaxial pe manivela 2 si un corp 3, pe care sunt fixate rigid console 4. Pe console 4 sunt montate role conice de moletare 5, fiecare dintre care sunt instalate pe axe 6. Rolele conice de moletare 5 formeaza dinti pe piesa de prelucrat 7, fixata rigid de masa 9 prin intermediul unor bride 8 care este amplasata coaxial fata de corp 10 cu posibilitatea de rotire. Dispozitivul adaugator mai include un traductor 13 legat cu un generator ultrasonic 14, si sistemul de actionare 15.
Patent MX-162690-A (MX)
Inventor: HOLTMAN DENNIS C
IPC: A61F13/514
Filed: 1984-07-19
Abstract: A disposable urinary pad is described as having high liquid impact capacity, high liquid retention, and allows the skin of the wearer to remain dry. The pad comprises a liquid-impermeable, substantially flexible shell (12) containing a superstructure (14) which is slightly compressible and capable of maintaining a void volume of liquid and an absorbent medium.
Patent NZ-207765-A (NZ)
Title: Plant expression of transferred dna(t-dna)from plasmids associated with agrobacterium sp
Inventor: HALL T C
IPC: A01H5/00
Filed: 1984-04-06
Abstract: There is provided a DNA shuttle vector comprising T-DNA having inserted therein a plant gene comprising a plant promoter and a plant structural gene, the plant promoter being adjacent to the 5 min -end of the plant structural gene and the plant structural gene being downstream from the plant promoter in the direction of transcription.
Patent NZ-218981-A (NZ)
Title: Method using ligand-labelled antigens or antibodies for measuring level of circulating antigens or antibodies
Inventor: EL SHAMI A S
IPC: G01N33/543
Filed: 1987-01-20
Abstract: A method for measuring the level of circulating antigen (Ag1), antibody (Ab1) or hapten (H) in a liquid sample, which comprises forming in a liquid phase reaction a soluble complex wherein said antigen (Ag1) antibody (Ab1) or hapten (H) is linked through, respectively, a specific antibody (Ab), antigen (Ag) or antihapten (Anti-H), to a matrix which is soluble in the liquid phase and carries a ligand (X), subsequently forming an insolubilised complex comprising a solid support linked to the ligand (X) of said soluble complex through an anti-ligand (Y), the insolubilised complex carrying a label (Z) linked to the antigen (Ag1) through an anti-antigen (Anti-Ag1), to the antibody (Ab1) through an anti-antibody (Anti-Ab1) or to the hapten (H), washing the insolubilised complex, and checking the washed insolubilised complex for the presence of the label (Z) to provide a measure of the level of said antigen (Ag1), antibody (Ab1) or hapten (H) in said sample.
Patent NZ-222015-A (NZ)
Title: 7-(meta-substituted phenylglycine)-1-carba-1-dethiacephalsporins and pharmaceutical compositions
Inventor: COOPER R D G
IPC: A61P35/00
Filed: 1987-10-01
Abstract: Compounds of the Formula I <CHEM> wherein R1 is C1 to C4 alkyl, and their pharmaceutically-acceptable salts are valuable antibiotics.
Patent NZ-225654-A (NZ)
Title: Anthracycline compositions containing l-cysteine; method for preparation thereof
Inventor: YASUHISA SAKAMAKI
IPC: A61K31/65
Filed: 1988-08-02
Abstract: A stabilized preparation, particularly, freeze-drying injection, of anthracycline, for example, (7S, 9S)-9-acetyl-9-amino-7-[(2-deoxy- beta -D-erythro-pentopyranosyl)oxy] -7,8,9,10-tetrahydro-6,11-dihydroxy-naphthacene-5,12-dione or salts thereof which comprises L-cysteine or salts thereof.
Patent NZ-228514-A (NZ)
Title: Aromatic ethers and fungicidal compositions
Inventor: SCHUETZ FRANZ
IPC: C07C69/736
Filed: 1989-03-29
Abstract: Ortho-substituted phenol ethers of the general formula I   <IMAGE> I where R1is C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio or amino which is unsubstituted or mono- or disubstituted by C1-C4-alkyl, R2 is C1-C4-alkyl, R3 is aryloxy, arylthio or arylalkoxy, the aromatic ring being unsubstituted or substituted by one or more of the following radicals: halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-alkylthio, C1-C2-haloalkyl, aryl, aryl-C1-C2-alkoxy, C1-C4-alkylcarbonyl, mono- or di-C1-C4-alkylsubstituted amino, cyano, nitro, X is CH or N, and Y is saturated or unsaturated C2-C12-alkylene, and fungicides containing these compounds.
Patent NZ-228738-A (NZ)
Title: Wrap-around carton with locking tabs
Inventor: SCHUSTER RICHARD LEE
IPC: B65D71/20
Filed: 1989-04-13
Abstract: A wrap-around carton with overlapping flaps overlying a substantially flat surface of the packaged article. A tab on the outer flap extends into a slot in the inner flap, with shoulders formed from a slot in the outer flap engaging the edge of the slot in the inner flap to mechanically connect the flaps together. In addition, a tab on the inner flap is inserted into the slot in the outer flap, whereby the inner flap tab urges the shoulders down so as to hold the locking mechanism in place and the edge of the slot in the outer flap holds the inner flap tab in place.
Patent NZ-233235-A (NZ)
Title: Stereoselective preparation of 8alpha,12-oxido-13,14,15,16-tetranorlabdane by dehydration with acidic aluminium oxide of 8#a#,12-dihydroxy-13,14,15,16-tetranorlabdane
Inventor: BRUNS KLAUS
IPC: C07D307/92
Filed: 1990-04-06
Abstract: PCT No. PCT/EP90/00541 Sec. 371 Date Oct. 11, 1991 Sec. 102(e) Date Oct. 11, 1991 PCT Filed Apr. 6, 1990 PCT Pub. No. WO90/12793 PCT Pub. Date Nov. 1, 1990.The invention relates to a process for the stereo-selective preparation of 8 alpha ,12-oxido-13,14,15,16-tetranorlabdane by dehydration of 8 alpha ,12-dihydroxy-13,14,15,16-tetranorlabdane with acid-charged aluminium oxides.
Patent NZ-234883-A (NZ)
Title: Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
Inventor: PETPIBOON PRASIT
IPC: C07D401/12
Filed: 1990-08-13
Abstract: Compounds having the formula I: <CHEM> are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, spontaneous abortion, dysmenorrhea, and migraine.
Patent NZ-236128-A (NZ)
Title: 9,10-bis(phenylethynyl)anthracene derivatives and their use in chemiluminescent systems
Inventor: ESSENFELD AMY P
IPC: C09K11/07
Filed: 1990-11-19
Abstract: Chemiluminescent mixtures utilizing tri and tetra alkyl substituted 9,10-bis(phenylethynyl)anthracene derivatives to provide higher chemiluminescence efficiencies in low temperature and high intensity-short duration applications. The preferred fluorescers are 1,2,4-trimethyl-9,10-bis(phenylethynyl) anthracene and 1,2,3,4- tetramethyl-9,10-bis(phenylethynyl)anthracene, which compounds are also part of the instant invention.
Patent NZ-236951-A (NZ)
Title: Substituted benzisoxazole derivatives and herbicidal compositions containing them
Inventor: CHRYSTAL EWAN JAMES TURNER
IPC: C07D413/12
Filed: 1991-01-30
Abstract: A herbicidal compound of formula (I) : <CHEM>  in which  Ar is an optionally subsitituted aryl or heterocyclic ring system; R<1> and R<2> are independently selected from H, optionally substituted alkyl, alkenyl or alkynyl, halogen, NR<a>R<b>, or R<1> and R<2> together with the carbon to which they are attached form an optionally substituted alkenyl or cycloalkyl group; R<3> is CO2R<4>, CN, COR<4>, CH2OR<4>, CH(OH)R<4>, CH(OR<4>)R<5>, CH2OSO2R<4>, CH2OSO3R<4>, CH2ONR<6>R<7>, CSNH2, COSR<4>, CSOR<4>, CONHSO2R<4>, CONR<6>R<7>, CONHNR<6>R<7>, CONHN<+>R<6>R<7>R<8> Y<->, CO2<->M<+> or COON=CR<6>R<7>;  M<+> is an agriculturally acceptable cation;  Y<-> is an agriculturally acceptable anion; R<4>, and R<5> are independently selected from H or an optionally substituted alkyl, aryl, alkenyl or alkynyl group; R<6>, R<7>, R<8>, R<9>, R<a> and R<b> are independently selected from H or an optionally substituted alkyl, alkenyl, aryl or alkynyl group or any two of R<6>, R<7>, R<8>, R<9>, R<a> and R<b> together with the atom to which they are attached form a cycloalkyl or heterocyclic ring;  R<6> and R<7> may also be a heterocyclic ring;  W is O or NR<1><0> where R<1><0> is H or lower alkyl;  X is (CH2)n, CH=CH, CH(OR<c>)CH2, COCH2; where R<c> is H or an optionally substituted alkyl, aryl, alkynyl or alkynyl group; and  n is O, 1 or 2. Process for the preparation of these compounds and compositions containing them are also described.
Patent NZ-240976-A (NZ)
Title: Castanospermine esters (i.e. octahydro-1,6,7,8-indolizinetetrol derivatives) and their use in anti-herpes antiviral medicaments
Inventor: TYMS ALBERT STANLEY
IPC: A61K31/44
Filed: 1991-12-13
Abstract: Castanospermine esters are active in the treatment of herpes viral infections.
Patent NZ-245331-A (NZ)
Title: Lipstick comprising 1-99% fatty wax; 0.001 to 20% aluminium salt colourant and 0.001 to 20% of c12-c60 fatty acid ester; preparation thereof
Inventor: CASTRO JOHN RICHARD
IPC: A61Q1/04
Filed: 1992-12-01
Abstract: A method is provided for producing a coloured cosmetic stick of reproducible hardness through utilizing a wax that has been treated with an alcohol to convert any naturally-occurring C12-C60 fatty acid into a respective ester. This esterified wax is then mixed with an aluminum salt colorant and then formed into a stick. There is also disclosed coloured cosmetic sticks produced through the aforementioned process.
Patent NZ-251886-A (NZ)
Title: Ribonucleotide reductase inhibitors and their production
Inventor: MCCARTHY JAMES RAY
IPC: C07F7/18
Filed: 1993-04-01
Abstract: The present invention is directed toward a novel process of 2'-exocyclic vinylfluoride derivatives of cytidine analogues (I) for use as ribonucleotide reductase inhibitors, wherein V is oxy or methylene and Y is hydrogen, C1-C4 alkyl or C1-C4 alkoxy.
Patent NZ-260308-A (NZ)
Title: 3(2-oxo-3-pyrrolidinylidenemethyl)cephalosporin derivatives, analogs thereof, intermediates, and medicaments
Inventor: ANGEHRN PETER
IPC: A61P31/04
Filed: 1994-04-14
Abstract: Cephalosporin derivatives of the general formula <CHEM>  wherein   R<1>   is an acyl group derived from a carboxylic acid; R<2>   is hydrogen, hydroxy, lower alkyl-Qm, cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl-Qm, aryl-Qm, aryloxy, aralkoxy or a heterocyclic ring, the lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, cycloalkenyl, lower alkynyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring being unsubstituted or substituted with at least one group selected from carboxy, amino, nitro, cyano, lower alkyl, lower alkoxy, hydroxy, halogen, -CONR<4>R<5>, -N(R<5>)COOR<9>, R<5>CO-, R<5>OCO- or R<5>COO- where R<4> is hydrogen, lower alkyl, or cycloalkyl; R<5> is hydrogen or lower alkyl; R<9> is hydrogen, lower alkyl, lower alkenyl or a carboxylic acid protecting group; Q   is -CO- or -SO2-; m   is 0 or 1; n   is 0, 1 or 2; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts. The products are antibacterially active.
Patent NZ-260652-A (NZ)
Title: Preparation of crystalline beta-lactam monohydrate
Inventor: NIST ROBERT LOUIS
IPC: C07D463/00
Filed: 1994-06-01
Abstract: Prodn. of the crystalline monohydrate form of loracarbef (I) comprises: (a) mixing a form of (I), other than the crystalline monohydrate form, in water at 30-60[deg]C; or (b) exposing a form of (I), other than the crystalline monohydrate form, to satd. steam at 90-100[deg]C.
Patent NZ-268587-A (NZ)
Title: 1-cycloalkyl substituted tetrahydroisoquinoline derivatives and pharmaceutical compositions
Inventor: SARGENT BRUCE JEREMY
IPC: C07D217/04
Filed: 1994-06-10
Abstract: PCT No. PCT/EP94/01926 Sec. 371 Date Dec. 21, 1995 Sec. 102(e) Date Dec. 21, 1995 PCT Filed Jun. 10, 1994 PCT Pub. No. WO95/00489 PCT Pub. Date Jan. 5, 1995Tetrahydroisoquinoline compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts thereof, in which: R1 represents one or more substituents selected from H, halo, hydroxy, alkyl (optionally substituted by hydroxy), alkoxy, alkylthio, alkylsulphinyl, alkyl-sulphonyl, nitro, cyano, polyhaloalkyl, polyhaloalkoxy, phenyl (optionally substituted by one or more of halo, alkyl or alkoxy), or R1 is optionally alkylated carbamoyl; R2 represents a saturated or unsaturated aliphatic group optionally substituted by hydroxy or alkoxy; E represents an alkylene chain optionally substituted by one or more alkyl groups; and G represents (a) optionally substituted saturated or unsaturated alicyclic group containing 3 to 8 carbon atoms, or (b) optionally substituted saturated or unsaturated aliphatic chain containing 1 to 12 carbon atoms, or (c) optionally substituted 5 or 6 membered heterocyclic ring containing one or more N or O atoms or SOn groups in which n is 0, 1 or 2; and O-acylated derivatives thereof which provide lipophilic esters have utility in analgesia or in the treatment of psychoses (e.g. schizophrenia), Parkinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment or in the relief of drug dependence or tardive dyskinesia.
Patent NZ-306918-A (NZ)
Title: Method for electronically exchanging one foreign currency for another, using cryptographically secure session
Inventor: ROSEN SHOLOM S
IPC: G07G1/12
Filed: 1996-04-19
Abstract: An electronic-monetary system having (1) banks or financial institutions that are coupled to a money generator device for generating and issuing to subscribing customers electronic money including electronic currency backed by demand deposits and electronic credit authorizations; (2) correspondent banks that accept and distribute the electronic money; (3) a plurality of transaction devices that are used by subscribers for storing electronic money, for performing money transactions with the on-line systems of the participating banks or for exchanging electronic money with other like transaction devices in off-line transactions; (4) teller devices, associated with the issuing and correspondent banks, for process handling and interfacing the transaction devices to the issuing and correspondent banks, and for interfacing between the issuing and correspondent banks themselves; (5) a clearing bank for balancing the electronic money accounts of the different issuing banks; (6) a data communications network for providing communications services to all components of the system; and (7) a security arrangement for maintaining the integrity of the system, and for detecting counterfeiting and tampering within the system. An embodiment of the invention includes a customer service module which handles lost money claims and links accounts to money modules for providing bank access.